Literature DB >> 3918103

Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue.

D Campana, G Janossy, M Bofill, L K Trejdosiewicz, D Ma, A V Hoffbrand, D Y Mason, A M Lebacq, H K Forster.   

Abstract

The phenotype of B lineage cells (TdT+, pre-B, IgM+, IgD-, and IgM+,IgD+) in infant and adult human bone marrow was compared with that of B cells seen in peripheral tissues such as tonsil and blood. The range of B cell-associated antibodies used included four reagents with greater than 90% reactivity on peripheral B cells: RFB4 and To15 (both p135, corresponding to CD22), RFB6 (p140 corresponding to CD21), and Y29/55, a unique B cell-specific antibody. In addition, AL-1, an antibody with virtually no reactivity against peripheral B cells was also used. The BM cell subpopulations were heterogeneous in respect of antibody reactivity. The TdT+, pre-B and IgM+, IgD- cells were AL-1+ but did not express membrane antigens recognized by the antibodies To15, RFB4 (CD22), and RFB6 (CD21). TdT+, pre-B cells, and 50% of IgM+, IgD- BM B cells were also unreactive with antibody Y29/55, the other 50% being Y29/55+. In contrast, the IgM+,IgD+ BM B cells, like peripheral B cells, were positive with antibodies To15, RFB4, RFB6, and Y29/55, but reacted only in small numbers with AL-1. The orderly differentiation-linked display of these antigens was also suggested by the findings that normal TdT+, pre-B, and IgM+,IgD- cells expressed the To15 and RFB4 (CD22) antigens in their cytoplasm (in the Golgi region). This observation was confirmed in malignant common acute lymphoblastic and pre-B blast cells, as well as in the corresponding permanent cell lines KM3 and NALM-6. In these lines the membrane expression of To15 and RFB4 could be induced by phorbol ester during a 48 to 72 hr culture period.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918103

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  An anti-CD45RO immunotoxin eliminates T cells latently infected with HIV-1 in vitro.

Authors:  C McCoig; G Van Dyke; C S Chou; L J Picker; O Ramilo; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Rapid method for detecting monoclonality in B cell lymphoma in lymph node aspirates using the polymerase chain reaction.

Authors:  J H Wan; P J Sykes; S R Orell; A A Morley
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

3.  Decreased expression of complement receptor type 2 (CR2) on neoplastic B cells of chronic lymphocytic leukaemia.

Authors:  J A Tooze; D H Bevan
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

4.  Functional and molecular characterization by the CB04 monoclonal antibody of a cell surface structure exerting C3-complement receptor activity.

Authors:  F Malavasi; A Funaro; G Bellone; F Caligaris-Cappio; E Berti; C Tetta; P Dellabona; S DeMaria; M Campogrande; A P Cappa
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

5.  Expression of HIS50 Ag: a rat homologue of mouse heat-stable antigen and human CD24 on B lymphoid cells in the rat.

Authors:  M H Hermans; G J Deenen; N De Boer; W Bo; F G Kroese; D Opstelten
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

Review 6.  Immunotoxins for the treatment of B-cell lymphomas.

Authors:  M A Ghetie; V Ghetie; E S Vitetta
Journal:  Mol Med       Date:  1997-07       Impact factor: 6.354

7.  A phenotypic study of B lymphocyte subpopulations in human bone marrow.

Authors:  M R Chapple; I C MacLennan; G D Johnson
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

8.  A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia.

Authors:  John Schindler; Srikanth Gajavelli; Farhad Ravandi; Yumin Shen; Samir Parekh; Ira Braunchweig; Stefan Barta; Victor Ghetie; Ellen Vitetta; Amit Verma
Journal:  Br J Haematol       Date:  2011-07-07       Impact factor: 6.998

9.  CD3+ CD8+ T cell lymphocytosis masking B cell leukaemia.

Authors:  J L Smith; D G Oscier; D G Haegert; D B Jones; M Howell; E Hodges; F K Stevenson; T J Hamblin
Journal:  J Clin Pathol       Date:  1988-07       Impact factor: 3.411

Review 10.  Phenotypic and genotypic characteristics of the human prothymocyte.

Authors:  J J van Dongen; W M Comans-Bitter
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.